Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway
Sheng‐Kai Hsu, Kai‐Chun Cheng, Miracle Oluebube Mgbeahuruike, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9453-9453
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation
Martina Kropp, Olga Golubnitschaja, Alena Mazuráková, et al.
The EPMA Journal (2023) Vol. 14, Iss. 1, pp. 21-42
Open Access | Times Cited: 184
Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities
Runyu Miao, Xinyi Fang, Yanjiao Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 85
Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments
Howida M. Nail, Chien‐Chih Chiu, Chung‐Hang Leung, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 64
Dose-Dependent Relationship Between Long-Term Metformin Use and the Risk of Diabetic Retinopathy: A Population-Based Cohort Study
Yu-Ching Li, Kuang‐Hua Huang, Yih Yang, et al.
Clinical Drug Investigation (2025)
Open Access | Times Cited: 2
Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort’s analysis
Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, et al.
International Journal of Retina and Vitreous (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Metformin ameliorates ferroptosis in cardiac ischemia and reperfusion by reducing NOX4 expression via promoting AMPKα
Zhenhua Wu, Yunpeng Bai, Yujuan Qi, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 886-896
Open Access | Times Cited: 21
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 19
Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3
Zongqiang Hu, Yingpeng Zhao, Laibang Li, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 8, pp. 6399-6413
Open Access | Times Cited: 19
Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
Trevor J. Plowman, Hannah Christensen, Myia Aiges, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5190-5190
Open Access | Times Cited: 8
A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
Elaine Chow, Aimin Yang, Colin Ho Lam Chung, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 442-442
Open Access | Times Cited: 23
Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer
Chengmin Deng, Lin Xiong, Yang Chen, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway
Yajiang Yuan, Xiangyi Fan, Zhanpeng Guo, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 21
Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
Dan Liang, Zhiyang Li, Zhaowei Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Effects of medications on hypoxia‐inducible factor in the retina: A review
Angela H. Kim, Masha Kolesnikova, Wei Kiong Ngo, et al.
Clinical and Experimental Ophthalmology (2023) Vol. 51, Iss. 3, pp. 205-216
Closed Access | Times Cited: 11
Biological function, regulatory mechanism, and clinical application of mannose in cancer
Haoyi Jin, Xi Liu, Hongxu Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188970-188970
Closed Access | Times Cited: 11
Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1760-1760
Open Access | Times Cited: 4
Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
Juliana C.N. Chan, Aimin Yang, Natural Chu, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 55-74
Closed Access | Times Cited: 4
High-Glucose-Induced Metabolic and Redox Alterations Are Distinctly Modulated by Various Antidiabetic Agents and Interventions Against FABP5/7, MITF and ANGPTL4 in Melanoma A375 Cells
Nami Nishikiori, Hiroshi Ohguro, Megumi Watanabe, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1014-1014
Open Access
Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin
Xingyuan Ma, Chao Sun, Xiao Ding, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Sarcopenia in independent oldest-old individuals treated for diabetes, with or without metformin: a case–control study
Maísa Braga Aguiar, Solomon Kim, Adriana Bruscato Bortoluzzo, et al.
Acta Diabetologica (2025)
Closed Access
Targeting Ferroptosis in Parkinson’s: Repurposing Diabetes Drugs as a Promising Treatment
Carmen Duță, Corina Muscurel, Carmen Beatrice Dogaru, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1516-1516
Open Access
The Combination of PPARα Agonist GW7647 and Imeglimin Has Potent Effects on High-Glucose-Induced Cellular Biological Responses in Human Retinal Pigment Epithelium Cells
Nami Nishikiori, Megumi Watanabe, Megumi Higashide, et al.
Bioengineering (2025) Vol. 12, Iss. 3, pp. 265-265
Open Access
Effect of oral resveratrol-loaded nanoliposomes on hyperlipidemia via toll-like receptor 3 and TIR domain-containing adaptor inducing interferon-β protein expression in an animal model
Nasrin Beheshtkhoo, Mohammad Amin Jadidi Kouhbanani, Seyed Mojtaba Daghighi, et al.
Journal of Liposome Research (2025), pp. 1-27
Closed Access
Human periodontal ligament stem cells and metformin to enhance periodontal regeneration in rats
Zeqing Zhao, Qingchen Qiao, Yaxi Sun, et al.
Journal of Dentistry (2025), pp. 105700-105700
Closed Access
The association between duration of metformin and sulfonylurea treatment and microvascular complications in patients with incident type 2 diabetes: a pooled cohort analysis
Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top